Anavex Life Sciences Corp (AVXL)

[BIOChecker4]

What it tells me is the company is years away from generating any sales revenue. If a regulatory approval were imminent, as some here would like to believe, there would be no need to make a point of having two years of cash on hand since the company would be cash flow positive much sooner. So, this is far from being a buy signal.